Research led by the Joldasbekov Institute of Mechanics and Engineering in Kazakhstan, reports that camel milk intake ...

First identified in 1989, eosinophilia-myalgia syndrome is a rare condition that produces inflammation in the muscles, lungs, and skin.

Intranasal delivery of a monoclonal IgG1 antibody targeting mugwort pollen protected mice from allergic rhinitis and asthma ...

Upstream Bio has dosed the first subject in the Phase II trial of verekitug in individuals with chronic obstructive pulmonary disease (COPD).

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, marking the second biologic approved as an add-on maintenance treatment ...

Etokimab (I-Mab Biopharma), which is optimized for common IL-33 gene polymorphisms, has completed patient recruitment in its Phase II trial. The strategic combination of IL-33 inhibitors with ...

New research has found that drinking camel milk can reduce the severity of asthma caused by house dust mites, a major trigger ...

Knopp Biosciences’ investigational, first-in-class drug, dexpramipexole, holds promise for patients with asthma and eosinophil-associated diseases.

Broadens global development program for verekitug into third indication, strengthening pipeline across severe respiratory diseases including chronic rhinosinusitis with nasal polyps (CRSwNP), severe ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...

A second transplant patient also became infected, leading their doctors to surmise that their new kidneys were likely to ...